News

Skyphos to Showcase Additive Lithography at the Microfluidics Consortium Open Day in Boston

Skyphos Technologies, a Virginia Tech Corporate Research Center company advancing micro-scale and additive lithography manufacturing, will participate in the Microfluidics Consortium Open Day Meeting in Boston, where the company has been invited to present in the Physical Microfluidics Hotseat and deliver a tabletop demonstration.

The Microfluidics Consortium convenes worldwide leaders, from research and industry, bringing together stakeholders from materials, device development, instrumentation, and applications to accelerate adoption of microfluidics-enabled products and services. The Boston meeting is part of the consortium’s international event series and is organized around expert talks, startup hot-seat pitches, live demonstrations, and face-to-face networking.

At the event, Skyphos will highlight its advanced micro-fabrication platform and vertically integrated approach, aimed at enabling scalable, high-precision production of microdevice architectures outside of the clean room at scale. Skyphos specializes in components and process development relevant to lab-on-a-chip systems and related applications.

Participation in the Physical Microfluidics Hot-Seat places Skyphos alongside emerging companies and thought leaders presenting new approaches in the fields of diagnostics, therapeutics, organ-on-chip, synthetic biology, and next-generation microfluidic systems. The consortium’s broader mission is to connect participants from across Europe, the United States, and Asia to help move promising microfluidics technologies from concept toward commercial use.

“Skyphos is building manufacturing infrastructure for the next generation of microfluidic devices,” said Elliot McAllister- Founder. “This invitation to Boston reflects a growing recognition that scalable microfabrication remains a key bottleneck to the field. Skyphos and others are showing that new manufacturing models can translate and grow strong techniques and applications. Getting cures from lab to fab.”

Located within the Virginia Tech Corporate Research Center community, Skyphos represents the kind of deep-tech company the CRC was built to support: a venture combining advanced engineering, research-driven innovation, and commercial ambition. The company’s participation in Boston underscores the reach of Virginia-based innovation in emerging sectors where manufacturing and life sciences intersect.

 

Recent News

07/09/2026

Quoin Pharmaceuticals Receives FDA IND Clearance to Initiate Phase 2 Study of QRX003 in Peeling Skin Syndrome

Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX), a late clinical-stage specialty pharmaceutical company focused on rare and orphan diseases, announced that the U.S. Food and Drug Administration (FDA) has cleared the Company’s Investigational New Drug (IND) application for QRX003 for the treatment of Peeling Skin Syndrome (PSS), enabling initiation of its planned Phase 2 clinical study. Quoin

07/07/2026

United Therapeutics Corporation Acquires Thymmune Therapeutics

United Therapeutics Corporation (Nasdaq: UTHR) announced it has acquired Thymmune Therapeutics, Inc. (Thymmune), a privately held, preclinical stage biotechnology company developing scalable, regenerative thymic cell therapies for the potential treatment of post-transplant organ tolerance, immunodeficiencies, and autoimmune diseases. The thymus is a critical organ for the development and proper function of key parts of the

07/07/2026

Governor Spanberger Announces Virginia Ranked #1 in Nation for Customized Workforce Training

Governor Abigail Spanberger announced today that Virginia is ranked number one in the United States for customized workforce training in the 22nd annual Business Facilities Rankings Report for the fourth consecutive year. Business Facilities, a leading national publication for economic development professionals, recognized the Virginia Talent Accelerator Program for its success in delivering workforce training